AKT1 and gastric cancer: Results indicate that NVP-BKM120, a pan-class I PI3K inhibitor, is able to inhibit mTOR downstream activation, but induces the phosphorylation of AKT and the activation of p-ERK or p-STAT3 in KRAS mutant gastric cancer cells.